ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Theophylline Anhydrous

Also known as: Theophylline, 1,3-Dimethylxanthine, Theophylline Anhydrous

Overview

Theophylline anhydrous, a xanthine derivative, is primarily used as a bronchodilator and phosphodiesterase inhibitor. While found in small amounts in tea and cocoa, it is mainly synthesized for medical applications. It is a well-studied compound for treating respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), with emerging research exploring its potential in taste and smell disorders. Theophylline works by relaxing bronchial smooth muscle and increasing cyclic AMP levels. It is available in various forms, including immediate-release and sustained-release tablets, and is typically administered orally. High-quality evidence supports its use in respiratory conditions, but further research is needed to validate its benefits in other areas. Due to its narrow therapeutic index, careful monitoring of serum levels is essential to avoid toxicity.

Benefits

Theophylline is primarily used to improve lung function in COPD and asthma, demonstrated by increased FEV1 (forced expiratory volume in one second) and reduced respiratory symptoms. Studies have shown that theophylline can increase FEV1 by approximately 12 mL compared to doxofylline in COPD patients. Emerging evidence suggests potential benefits in improving taste and smell disorders, particularly with intranasal administration. Theophylline is effective in both children and adults with asthma, providing relief from bronchoconstriction and improving overall respiratory function. However, it is generally not considered a first-line treatment and is often used adjunctively with other bronchodilators.

How it works

Theophylline primarily functions as a phosphodiesterase inhibitor, which increases intracellular cyclic AMP levels. This increase leads to the relaxation of smooth muscles in the airways, resulting in bronchodilation. Additionally, theophylline interacts with the respiratory system, influencing cardiovascular functions. Its molecular targets include phosphodiesterase enzymes, which are crucial in regulating inflammatory and immune responses. Theophylline is well absorbed orally, exhibiting approximately 100% bioavailability, allowing it to exert its effects throughout the body.

Side effects

Theophylline, while effective, has a narrow therapeutic index, necessitating careful monitoring to avoid toxicity. Common side effects include nausea, vomiting, headache, and insomnia, occurring in more than 5% of users. Less common side effects (1-5%) involve more severe reactions such as seizures and arrhythmias. Rare side effects, affecting less than 1% of users, include severe allergic reactions. Theophylline interacts with several medications, including beta-blockers and certain antibiotics, potentially altering their effects. It is contraindicated in individuals with severe heart disease or peptic ulcer disease. Dose adjustments are often required for elderly patients or those with liver or kidney impairment. Due to these potential risks, theophylline should be used with caution and under close medical supervision.

Dosage

For respiratory conditions, theophylline typically starts at an oral dose of 100-200 mg. Optimal dosage ranges are generally between 200-400 mg administered every 6-8 hours for chronic management. The maximum safe dose should not exceed 800 mg per day. It is advisable to take theophylline with meals to mitigate gastrointestinal side effects. Sustained-release formulations are available to improve patient compliance by reducing the frequency of dosing. Food does not significantly affect the absorption of theophylline. Due to its narrow therapeutic index, serum levels should be monitored regularly to ensure the dosage remains within the therapeutic range and to avoid toxicity.

FAQs

How should I take Theophylline?

Take Theophylline with meals to reduce gastrointestinal side effects. Follow your doctor's prescribed dosage and timing carefully. Sustained-release forms can help with compliance.

What are the expected results from Theophylline?

You should expect an improvement in respiratory symptoms, such as easier breathing and reduced wheezing, within hours to days of starting Theophylline.

Why is monitoring important when taking Theophylline?

Theophylline has a narrow therapeutic index, meaning the difference between an effective dose and a toxic dose is small. Monitoring serum levels is crucial to ensure safety.

Is Theophylline a first-line treatment for asthma?

No, Theophylline is not typically a first-line treatment for asthma or COPD. It is often used adjunctively with other bronchodilators to manage symptoms.

What should I do if I experience side effects?

If you experience side effects such as nausea, vomiting, or headache, contact your doctor. Severe side effects like seizures require immediate medical attention.

Research Sources

  • https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/1392510 – An open-label pilot study investigated intranasal theophylline for hyposmia and hypogeusia in 10 patients over 4 weeks. The study found that intranasal theophylline improved taste and smell more effectively than oral forms, suggesting a potential benefit for patients with taste and smell disorders. However, the study's limitations include a small sample size and an open-label design, indicating a need for further research.
  • https://pubmed.ncbi.nlm.nih.gov/29391776/ – A systematic review and meta-analysis of 42 trials, encompassing 52 study arms, assessed the efficacy and side effects of intravenous theophylline in acute asthma. The analysis concluded that theophylline is a cost-effective and safe option for managing acute asthma when used in conjunction with bronchodilators. The study acknowledges heterogeneity in study designs as a limitation, but its comprehensive analysis provides moderate to high-quality evidence supporting theophylline's use in acute asthma.
  • https://publications.ersnet.org/content/errev/27/148/180010 – A network meta-analysis involving 998 COPD patients evaluated the efficacy and safety profile of xanthines, including theophylline. The study found that theophylline is effective in treating COPD but carries a higher risk of adverse effects compared to doxofylline. Variability in study durations and populations was noted as a limitation, but the robust statistical analysis provides high-quality evidence regarding the use of theophylline in COPD management.
  • https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0251348 – This study investigates the effects of theophylline on human olfactory receptor neurons. The research indicates that theophylline can modulate olfactory receptor activity, providing a potential mechanism for its effects on taste and smell perception. This study provides insights into the molecular mechanisms underlying theophylline's potential benefits in treating taste and smell disorders.
  • https://www.sigmaaldrich.com/US/en/tech-docs/paper/445572 – This technical document from Sigma-Aldrich provides detailed information on the properties, handling, and applications of theophylline. It serves as a valuable resource for researchers and clinicians, offering insights into the chemical characteristics and usage guidelines for theophylline in various experimental and therapeutic contexts.